Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1988 Feb;85(4):1086-90.
doi: 10.1073/pnas.85.4.1086.

Differential expression of DNA topoisomerases I and II during the eukaryotic cell cycle

Affiliations
Comparative Study

Differential expression of DNA topoisomerases I and II during the eukaryotic cell cycle

M M Heck et al. Proc Natl Acad Sci U S A. 1988 Feb.

Abstract

We have utilized antibody probes to examine the expression of DNA topoisomerases I and II and chromosome scaffold protein Sc-2 in normal and transformed cells. Neither topoisomerase I nor Sc-2 shows significant fluctuations in content or stability across the cell cycle. In contrast, topoisomerase II undergoes significant cell cycle-dependent alterations in both amount and stability. As cells progress from mitosis into G1, much of the topoisomerase II is degraded. During the first 2 hr of G1, the half life of topoisomerase II is decreased from that measured in asynchronous cell populations by a factor of 7. This suggests that the chromosome condensation/decondensation cycle is coupled to a parallel cycle of synthesis and degradation of topoisomerase II. In control experiments, we also found that the half-life of topoisomerase II is shorter in normal cells than in transformed cells by a factor of 4. Since the number of copies of topoisomerase II per cell is also lower in normal cells, this suggests that control of topoisomerase II stability is altered upon transformation. The stability of topoisomerase I and Sc-2 does not differ significantly between normal and transformed cells.

PubMed Disclaimer

Similar articles

Cited by

References

    1. FEBS Lett. 1984 Oct 29;176(2):431-5 - PubMed
    1. EMBO J. 1986 May;5(5):1003-10 - PubMed
    1. J Biol Chem. 1985 Feb 25;260(4):2475-82 - PubMed
    1. Cell. 1985 Jun;41(2):553-63 - PubMed
    1. J Cell Biol. 1985 May;100(5):1706-15 - PubMed

Publication types

Substances